Edition:
United States

Jazz Pharmaceuticals PLC (JAZZ.O)

JAZZ.O on Nasdaq

139.16USD
17 May 2019
Change (% chg)

$-0.21 (-0.15%)
Prev Close
$139.37
Open
$138.70
Day's High
$140.83
Day's Low
$138.42
Volume
271,119
Avg. Vol
630,339
52-wk High
$184.00
52-wk Low
$113.52

About

Jazz Pharmaceuticals Public Limited Company is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. The Company's lead... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $8,797.71
Shares Outstanding(Mil.): 60.06
Dividend: --
Yield (%): --

Financials

  JAZZ.O Industry Sector
P/E (TTM): 22.31 29.30 32.55
EPS (TTM): 6.57 -- --
ROI: 10.38 14.23 13.82
ROE: 20.73 15.46 15.24

Drugmakers Jazz, Alexion, Lundbeck to pay $123 million to resolve U.S. charity kickback probe

BOSTON Three drugmakers will pay $122.6 million to resolve claims they used charities that help cover Medicare patients' out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging use of their medications, including some expensive ones.

Apr 04 2019

UPDATE 3-Drugmakers Jazz, Alexion, Lundbeck to pay $123 mln to resolve U.S. charity kickback probe

BOSTON, April 4 Three drugmakers will pay $122.6 million to resolve claims they used charities that help cover Medicare patients' out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging use of their medications, including some expensive ones.

Apr 04 2019

Earnings vs. Estimates